跳至主要内容
临床试验/CTRI/2025/06/089287
CTRI/2025/06/089287尚未招募3 期

Randomized clinical trial of Mudgadya Ghrita in the Management of Asrigdara(Abnormal Uterine Bleeding)

Mousumi Boro1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Decrease in symptoms like

研究概览

简要总结

This is a comparative study to establish the efficacy of mudgadya ghrita in the management of Asrigdara

Total number of patients to be studied is 60 where each group contains 30 samples

30 patients will be given mudgadya ghrita and rest 30 patients will be given tranexamic acid for a total of 3 months

patients will be followed up after every menstrual cycle for 3 months

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Age group from 18 years to 50 years Having abnormal uterine bleeding considering duration and quantity of bleeding during menstruation.

排除标准

  • Malignant patients Coagulation disorders Severe anaemia Post menopausal bleeding Patients with major disease like diabetes mellitus, asthma, kidney disease, liver disease Uterine fibroid.

结局指标

主要结局

Decrease in symptoms like

时间窗: 1 month

1.srava pramana(amount of bleeding)

时间窗: 1 month

2. Srava kaal( duration of bleeding)

时间窗: 1 month

3. Rituchakra avadhi(length of menstrual cycle)

时间窗: 1 month

4. Angamarda(body ache)

时间窗: 1 month

5. Vedana(pain during menstruation)

时间窗: 1 month

次要结局

  • Marked improvement has noticed in amount, duration of bleeding, length of menstrual cycle, body ache, pain during menstruation(3 months)

研究者

发起方
Mousumi Boro
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Mousumi Boro

Govt Ayurvedic College and Hospital

研究点 (1)

Loading locations...

相似试验